PerspectiveGenomic Medicine

The Emergence of Genome-Based Drug Repositioning

See allHide authors and affiliations

Science Translational Medicine  17 Aug 2011:
Vol. 3, Issue 96, pp. 96ps35
DOI: 10.1126/scitranslmed.3001512

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


In a pair of papers in this issue of Science Translational Medicine, Butte et al. provide a concrete example of how reinterpreting and comparing genome-wide metrics allows us to effectively hypothesize which drugs from one disease-indication can be repurposed for another disease. The shift toward integrative genome-wide computational approaches has precedence in insightful scalar theories of biological information. Here, we discuss how this recent work in drug repurposing adheres to and takes advantage of the concepts surrounding this information paradigm.


  • Citation: Y. A. Lussier, J. L. Chen, The Emergence of Genome-Based Drug Repositioning. Sci. Transl. Med. 3, 96ps35 (2011).

View Full Text

Stay Connected to Science Translational Medicine